Pfizer (PFE) And BioNTech (BNTX) Aims To Increase Coronavirus Vaccine Production This Year

Pfizer (PFE) and BioNTech (BNTX) plan to produce 2 billion doses of the coronavirus vaccine this year, instead of 1.3 billion doses initially planned, to meet the increasing global demand.


5 Stocks to make up the PERFECT 2021 gold portfolio

Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.

Click here to download your free report right away

Sponsored


More than half the above production has already been signed by the two pharmaceutical companies, according to a presentation by BioNTech which took place on Monday.

The company also announced that with the increase in production which will now be available, BioNTech (BNTX) would introduce another change to the vaccine vial label, which allows physicians to extract six doses instead of five from each vial.

As part of the production increase, the company will also open a new manufacturing facility in Marburg, Germany that will be operational by the end of February, with an annual production capacity of up to 750 million doses, according to a presentation given by BioNTech.

Furthermore, the pharmaceutical manufacturer announced that it was working diligently to expedite the increasing contributions of suppliers and employees involved in the manufacturing process.

This announcement comes when Europe faces the new and fastest-spreading coronavirus strain initially found in the UK. The European Union has already struck a new deal with Pfizer and BioNTech, allowing it to double the number of vaccines up to 600 million doses.

Pfizer (PFE) / BioNTech (BNTX) move is also expected to help meet greater demand from the US shortly. The President-elect, Joe Biden, has vowed to immediately distribute vaccines upon taking office, to counteract the global epidemic in his country. Half of the existing doses of the required vaccine held back to ensure that those who have already received the vaccination get the second dose of the vaccination in the US.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Lloyd Martinez
I am resigned and living in South Florida. I delighted in a fruitful and fluctuated vocation as a writer, business financier, venture broker, city treasurer, speculation counselor, NASD mediator, specialist, and tenured college educator. My scholarly accreditations incorporate having earned an experts degree in Economics and a doctorate certificate in Finance.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

Velodyne Lidar Inc. (VLDR): Continues Bringing Light To Investors Everywhere

The laser radar manufacturer, Velodyne Lidar (VLDR), announced that it had received a multi-year contract. Sales of the company are expected to grow significantly...

Private Investors Pumped GameStop (GME) Stock Up

Shares of GameStop Corp (GME) video games grew by 144.8 percent, to $159.18, backed by mid-session trade. In contrast, the company's shares were worth...

Related Articles

Velodyne Lidar Inc. (VLDR): Continues Bringing Light To Investors Everywhere

The laser radar manufacturer, Velodyne Lidar (VLDR), announced that it had received a multi-year contract. Sales of the company are expected to grow significantly...

Private Investors Pumped GameStop (GME) Stock Up

Shares of GameStop Corp (GME) video games grew by 144.8 percent, to $159.18, backed by mid-session trade. In contrast, the company's shares were worth...

DDOG Stock: Datadog Inc (DDOG) Is Still Worth a Bite

Since the start of the year, Datadog Inc. (NASDAQ: DDOG) shares have soared by 150%. Many citations confirm the company's position as one of...

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.